🇺🇸 FDA
Pipeline program

Low-dose RSV mRNA vaccine

PRO-mRSV-1001

Phase 1 mab active

Quick answer

Low-dose RSV mRNA vaccine for RSV is a Phase 1 program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
SINOVAC BIOTECH LTD
Indication
RSV
Phase
Phase 1
Modality
mab
Status
active

Clinical trials